InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (16 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
16
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Cohen Joshua B, Chairman & CEO. Director active across 1 company, notably Amylyx Pharmaceuticals, Inc.. Cumulatively, 28 disclosures have been logged. Breakdown: 0 buy · 16 sells. Total volume traded: €6.1m. History available since 6 January 2022. The latest transaction was filed on 18 August 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Cohen Joshua B
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations28 total
60,039 shares0Common StockSEC:0001193125-26-359675:0
248,865 shares0Common StockSEC:0001193125-26-098440:0
29,282 shares@ US$14.4844.7% of flowCommon StockSEC:0001193125-26-091442:0
15,500 shares@ US$14.68342.5% of flowCommon StockSEC:0001193125-26-037552:0
197,182 shares@ US$7.5719.3% of flowCommon StockSEC:0001193125-26-017057:0
136,193 shares@ US$13.589524.0% of flowCommon StockSEC:0001193125-26-017057:1
2,818 shares@ US$7.570.3% of flowCommon StockSEC:0001193125-26-017057:2
1,974 shares@ US$13.82930.4% of flowCommon StockSEC:0001193125-26-017057:3
7,715 shares@ US$11.09481.0% of flowCommon StockSEC:0001193125-26-007666:0
29,733 shares@ US$14.34335.2% of flowCommon StockSEC:0001193125-25-228340:0
21,490 shares@ US$3.46591.0% of flowCommon StockSEC:0000950170-25-049513:0
180,118 shares0Common StockSEC:0000950170-25-036708:0
4,595 shares@ US$3.16630.2% of flowCommon StockSEC:0000950170-25-033719:0
11,851 shares@ US$3.46870.6% of flowCommon StockSEC:0000950170-25-014610:0
7,471 shares@ US$4.04660.4% of flowCommon StockSEC:0000950170-25-003531:0
18,589 shares@ US$3.19620.8% of flowCommon StockSEC:0000950170-24-111811:0
1,857 shares@ US$1.570.0% of flowCommon StockSEC:0000950170-24-109397:0
34,449 shares@ US$1.570.7% of flowCommon StockSEC:0000950170-24-106915:0
179,850 shares0Common StockSEC:0000950170-24-045696:0
4,135 shares@ US$18.72791.1% of flowCommon StockSEC:0000950170-24-027923:0
126,667 shares0Common StockSEC:0000950170-24-022413:0
5,841 shares@ US$16.32811.3% of flowCommon StockSEC:0000950170-24-003981:0
63,694 shares@ US$1.571.4% of flowCommon StockSEC:0000950170-23-065259:0
96,076 shares@ US$31.839643.6% of flowCommon StockSEC:0000899243-23-009171:0
4,122 shares@ US$36.07892.1% of flowCommon StockSEC:0000899243-23-001524:0
25 of 28 declarations
About Cohen Joshua B
Cohen Joshua B is Co-Président-Directeur Général and Co-Chief Executive Officer at Amylyx Pharmaceuticals, Inc. He has filed 27 disclosures in total, and across the sampled recent filings from 2022-01-10 to 2026-03-09, the dominant transaction type is selling, with EUR 0 of buys and EUR 6,062,202 of sales.
